Tailored Mesoporous Silica Nanoparticles for Controlled Drug Delivery: Platform Fabrication, Targeted Delivery, and Computational Design and Analysis
- PMID: 27145854
- DOI: 10.2174/1389557516666160505114814
Tailored Mesoporous Silica Nanoparticles for Controlled Drug Delivery: Platform Fabrication, Targeted Delivery, and Computational Design and Analysis
Abstract
Mesoporous silica nanoparticles (MSNs) are exceptionally promising drug carriers for controlled drug delivery systems because their morphology, pore structure, pore volume and pore size can be well tailored to obtain certain drug release profiles. Moreover, they possess the ability to specifically transport and deliver anti-cancer drugs when targeting molecules are properly grafted onto their surface. MSNs based drug delivery systems have the potential to revolutionize cancer therapy. This review provides a comprehensive overview of the fabrication, modification of MSNs and their applications in tumour-targeted delivery. In addition, the characterization and analysis of MSNs with computer aided strategies were described. The existing issues and future prospective concerning the applications of MSNs as drug carriers for controlled drug delivery systems were discussed.
Keywords: Computational design; controlled release; mesoporous silica nanoparticles (MSN); mesoporous silica nanoparticles; nanocarriers; targeted drug delivery..
Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.org.
Similar articles
-
Polydopamine-based surface modification of mesoporous silica nanoparticles as pH-sensitive drug delivery vehicles for cancer therapy.J Colloid Interface Sci. 2016 Feb 1;463:279-87. doi: 10.1016/j.jcis.2015.11.001. Epub 2015 Nov 3. J Colloid Interface Sci. 2016. PMID: 26550786
-
Chitosan-capped mesoporous silica nanoparticles as pH-responsive nanocarriers for controlled drug release.Chem Asian J. 2014 Jan;9(1):319-27. doi: 10.1002/asia.201301105. Epub 2013 Oct 2. Chem Asian J. 2014. PMID: 24115568
-
Mesoporous silica nanoparticles: synthesis, biocompatibility and drug delivery.Adv Mater. 2012 Mar 22;24(12):1504-34. doi: 10.1002/adma.201104763. Epub 2012 Feb 29. Adv Mater. 2012. PMID: 22378538 Review.
-
Polymer-Brush-Grafted Mesoporous Silica Nanoparticles for Triggered Drug Delivery.Chemphyschem. 2018 Aug 17;19(16):1956-1964. doi: 10.1002/cphc.201800018. Epub 2018 Apr 14. Chemphyschem. 2018. PMID: 29575338 Review.
-
Mesoporous silica nanoparticles for therapeutic/diagnostic applications.Biomed Pharmacother. 2019 Jan;109:1100-1111. doi: 10.1016/j.biopha.2018.10.167. Epub 2018 Nov 6. Biomed Pharmacother. 2019. PMID: 30551360 Review.
Cited by
-
Multifunctional cell membranes-based nano-carriers for targeted therapies: a review of recent trends and future perspective.Drug Deliv. 2023 Dec;30(1):2288797. doi: 10.1080/10717544.2023.2288797. Epub 2023 Dec 9. Drug Deliv. 2023. PMID: 38069500 Free PMC article. Review.
-
pH-responsive silica nanocarriers of olaparib for augmenting anticancer activity: development, characterization, and in vitro cytotoxicity study against MCF-7 breast cancer cells.3 Biotech. 2025 Jun;15(6):190. doi: 10.1007/s13205-025-04364-9. Epub 2025 May 27. 3 Biotech. 2025. PMID: 40443547
-
An Update on Mesoporous Silica Nanoparticle Applications in Nanomedicine.Pharmaceutics. 2021 Jul 12;13(7):1067. doi: 10.3390/pharmaceutics13071067. Pharmaceutics. 2021. PMID: 34371758 Free PMC article. Review.
-
Current Status of Gene Therapy in Hepatocellular Carcinoma.Cancers (Basel). 2019 Aug 28;11(9):1265. doi: 10.3390/cancers11091265. Cancers (Basel). 2019. PMID: 31466358 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous